SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001546927-16-000414
Filing Date
2016-02-12
Accepted
2016-02-12 13:10:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 opaleye13gamendamogenv1.txt SC 13G/A 13651
  Complete submission text file 0001546927-16-000414.txt   15355
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83793 | Film No.: 161417207
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110
Business Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A